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BACKGROUND: The role of adult weight change in breast cancer (BC) risk is unclear in Japanese women.
METHODS: A total of 10106 postmenopausal women aged 40–64 years (the Miyagi Cohort) were followed from 1990 to 2003, and
108 BC cases were identified. Hazard ratios (HRs) were estimated according to body mass index (BMI) at the current age and at the
of age 20 years, and weight change since age 20 years.
RESULTS:Higher current BMI was associated with an increased risk of BC (P for trend¼0.02), whereas higher BMI at the age 20 years
was inversely associated with this risk (P for trend¼0.002). There was a significant association between weight change since age
20 years and BC risk (P for trend¼0.0086). Compared with stable weight, HR was 0.35 for weight loss of 5kg or more (P for weight
loss trend¼0.04) and 1.55 for weight gain of 12kg or more (P for weight gain trend¼0.05).
CONCLUSION: Adiposity at younger and current age has differential effects on BC risk among postmenopausal women; weight gain in
adulthood being associated with an increased, and weight loss with a decreased risk.
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The incidence of breast cancer (BC) shows variations among
countries and although Japan has a lower risk of BC than Western
countries, its age-standardised incidence is the highest among
female cancers, and it is increasing (Matsuda et al, 2008). The
increase of BC incidence may be attributed to a change in the
proportion of women in the population who have reproductive and
anthropometric risk factors (Minami et al, 2004). Among such risk
factors, the associations between adiposity and BC risk have been
extensively investigated, mainly in the Western countries
(Lahmann et al, 2004; Morimoto et al, 2002; Reeves et al, 2007).
In relation to adiposity, weight gain has also been associated with
an increased risk of postmenopausal BC in several prospective
studies (Ahn et al, 2007; Barnes-Josiah et al, 1995; Eliassen et al,
2006; Feigelson et al, 2004; Lahmann et al, 2005). In Japan,
however, few prospective studies have evaluated the association
with adiposity (Iwasaki et al, 2007; Kuriyama et al, 2005). Also,
data are sparse regarding the effect of body weight change (Hirose
et al, 1999; Kyogoku et al, 1990).
We therefore conducted a population-based cohort study, in
which we evaluated the association of adiposity in different
periods, that is, at current age and at age 20 years, with BC risk and
examined the change in risk resulting from body weight gain and
loss since the age of 20 years among postmenopausal Japanese
women.
MATERIALS AND METHODS
Our analysis used the Miyagi Cohort Study, whose design has been
described in detail elsewhere (Fukao et al, 1995; Kawai et al, 2010).
Briefly, 25279 men and 26642 women aged 40–64 years living in
14 municipalities, selected randomly from among the 62 munici-
palities in Miyagi Prefecture, Northeastern Japan, were entered
into a cohort on 1 June 1990. A self-administered questionnaire on
various health aspects was delivered to these subjects between June
and August 1990. Usable questionnaires were returned by 22836
men (90.3%) and 24769 women (93.0%). After excluding men,
women with a history of cancer (n¼705), who were premeno-
pausal (n¼9131), with undefined menopausal status (n¼642) and
for whom data on menopausal status were missing (n¼2927),
11364 postmenopausal women remained (Kawai et al, 2010). After
further excluding women with missing data or extreme values for
current height or current weight or weight at age 20 years
(n¼1258), 10106 postmenopausal women contributed to this
study. The study protocol was approved by the institutional review
board of Tohoku University School of Medicine. We considered
the return of self-administered questionnaires signed by the
subjects to imply their consent to participate in the study.
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height (centimeters) and weight (kilograms) and weight at age
20 years and details of general lifestyle including menstrual and
reproductive histories. The self-reported current height and weight
data were highly correlated with measured data (correlation
coefficient: 0.82 for height and 0.97 for weight) in a subsample
of postmenopausal women (n¼2921), although we were unable to
validate the data for weight at age 20 years.
As a measure of adiposity, body mass index (BMI) was used. The
BMI at the current age and at age 20 years, calculated as weight
divided by the square of current height (kgm
–2), respectively. To
analyze BC risk for adiposity in the different periods, the study
women were categorised using quartile points of BMI at age
20 years, respectively: o20.5, X20.5–o22.0, X22.0–o23.8 and
X23.8. Subjects with a current BMI of 23.8 and higher were
further divided into two groups on the basis of median value in
the range between 23.8 and the largest current BMI, as the BMI at
the current age was skewed towards a higher value than at age
20 years. Finally, women were categorised as follows: current BMI
o20.5, X20.5–o22.0, X22.0–o23.8, X23.8–o25.9 and X25.9;
BMI at age 20 o20.5, X20.5–o22.0, X22.0–o23.8 and X23.8.
Weight change from age 20 years to the current age was calculated
as the difference between current weight and weight at age 20.
Subjects were also categorised into seven groups as follows: weight
loss of p–5 and 4–5 to p–2, stable weight of 4–2 to oþ2,
and weight gain of Xþ2t ooþ5, Xþ5t ooþ8, Xþ8t o
oþ12 and Xþ12. The categorisation of weight loss was based
on the median value, and that of weight gain was determined using
quintile values.
Women were followed from the start of the study (1 June 1990)
until 31 December 2003. The end point of our analysis was BC
defined as the topography codes C50.0–C50.9 according to the
International Classification of Disease for Oncology, Second
Edition, and confirmed by the Miyagi Prefecture Cancer Registry,
one of the oldest and most accurate population-based in Japan
(Curado et al, 2007). In this registry, the percentage registered
by death certificates only for BC was 2.5% during 1991–2003.
A follow-up committee was also established, consisting of the
Miyagi Cancer Society, the Divisions of Community Health of
all 14 municipalities, the Department of Health and Welfare,
Miyagi Prefectural Government, and the Division of Epidemiology,
Tohoku University School of Medicine. The committee periodi-
cally reviewed the residential registration record of each munici-
pality. During the study period, 491 women (4.9%) were lost to
follow-up because of emigration.
Statistical analysis
The person-years of follow-up were counted for each of the
subjects from the start of the study (1 June 1990) until the date of
diagnosis of BC, the date of emigration from the study area, the
date of death, or the end of follow-up (31 December 2003),
whichever occurred first. The mean follow-up period was 12.8
years. The Cox proportional–hazard regression model was used to
estimate BC hazard ratios (HRs) and 95% confidence intervals
(CIs) according to category of exposure variable, that is, BMI at
the current age, BMI at age 20 years and weight change from age
20 years to the current age, and to adjust for confounding variables
(Cox, 1972). Linear trends, which were tested using the Cox model
by treating each exposure category as a continuous variable, were
regarded as significant if P-values were o0.05. We considered the
following variables as potential confounders: age, education level,
cigarette smoking, alcohol drinking, and time spent walking, which
are known or suspected risk factors for BC. Menstrual and
reproductive factors, exogenous female hormone use, and history
of BC in the mother or sisters, some of which had been established
as risk factors in our previous study (Kawai et al, 2010), were also
considered to be adjusted for each other. In the analysis of weight
change, height and weight at age 20 years were further adjusted for
(Eliassen et al, 2006). Missing values for confounders were treated
as an additional variable category, and were included in the model.
To evaluate any independent effect of BMI during the different
periods, analysis adjusting for both BMIs each other was also
conducted. All statistical analyses were performed using the SAS
software package (version 9.1; SAS Institute, Cary, NC ,USA).
RESULTS
The characteristics of the study subjects are presented in Tables 1
and 2. The subjects with a higher current BMI were less likely to
smoke, whereas the subjects with a higher BMI at age 20 years
tended to be older and to have a shorter period of education
(Table 1). A total of 64.8% of the subjects had gained more than
2kg since age 20 years (Table 2). The subjects who lost weight were
heavier at age 20 years.
During 129891 person-years of follow-up, 108 BC cases were
documented. Table 3 shows the HRs and 95% CIs according to
current BMI and BMI at age 20 years. After adjustment for
confounding variables, current BMI was marginally associated
with an increased BC risk (P for trend in multivariate-adjusted
model 1¼0.07). The BMI at age 20 years was inversely associated
risk (P for trend in multivariate-adjusted model 1¼0.01).
Postmenopausal women with a BMI of X23.8 at age 20 years
showed half the risk (multivariate-adjusted HR¼0.44, 95% CI:
0.24–0.81) of women with a BMI of o20.5. Multivariate analysis
adjusting for both BMIs each other demonstrated a stronger
inverse association for BMI at age 20 years (P for trend in
multivariate-adjusted model 2¼0.002). The association of current
BMI with risk was statistically significant (P for trend¼0.02).
Weight change since the age of age 20 years was significantly
associated with the risk (multivariate-adjusted P for trend¼
0.0086) (Table 4). Compared with women whose weight had been
stable (lost or gained o2.0kg), those who lost 5kg or more were
at a lower risk (multivariate-adjusted HR 0.35, 95% CI: 0.11–1.10).
Women with a weight gain of 12kg or more appeared to have a
higher risk (HR 1.55, 95% CI: 0.70–3.45). According to weight
loss and gain, weight loss was associated with a decreased risk
(P for weight loss trend¼0.04), and weight gain with an increased
risk (P for weight gain trend ¼0.05). Although the data are not
shown in the table, stratified analysis by the BMI at age 20 years
revealed a clearer inverse association with weight loss among
women who were heavier at age 20 years (BMI at age 20 years
X23.8; P for weight loss trend¼0.01).
DISCUSSION
In this population-based cohort study, we found associations
between adulthood adiposity and weight change and BC risk
among postmenopausal women. Risk differed for BMI between
that at current age and that at age 20 years. Weight change from
age 20 to current age was significantly associated with risk. These
results provide some insight into the significance of adiposity and
weight change in terms of BC risk in postmenopausal Japanese
women.
This study found a positive association of current BMI with
postmenopausal BC risk consistent with previous prospective
studies (Iwasaki et al, 2007; Kuriyama et al, 2005; Lahmann et al,
2004; Morimoto et al, 2002; Reeves et al, 2007), and the fact that
postmenopausal obese women have more oestrogens than lean
women (Potischman et al, 1996), has a central role in BC aetiology.
After menopause, oestrogen is synthesised mainly by aromatase in
adipose tissue (Bulun et al, 2005). Another mechanism is that
obese women may be in a state of hyperinsulinemia, insulin being
a growth factor for BC cells. Insulin-like growth factor I may also
affect risk among heavier women (Muti et al, 2002). On the other
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with a decreased postmenopausal risk. This inverse association,
which has also been observed in the Western countries (Ahn et al,
2007; Morimoto et al, 2002; Sellers et al, 1992; van den Brandt et al,
1997), was independent of the effect of current BMI. The Nurses’
Health Study recently reported the independent protective effect of
body fatness at young age using a pictogram (Baer et al, 2010).
Although the mechanisms explaining this inverse association are
poorly understood, lower serum oestradiol and progesterone levels
and anovulation among young obese women may reduce BC risk
after menopause (Potischman et al, 1996).
There was a significant association between weight change
since age 20 and postmenopausal risk. Weight gain was associ-
ated with an increased risk, and weight loss with a decreased risk.
Table 1 Characteristics of study population according to body mass index (BMI)
o20.5 p20.5 o22.0 p22.0 o23.8 p23.8 o25.9 p25.9
Current BMI
Number of subjects 1209 1497 2335 2516 2549
Age (mean, years) 57.2±4.5 57.0±4.4 57.1±4.3 57.2±4.3 57.5±4.2
Occupation (no occupation/housewife, %) 15.4 15.5 17.3 16.6 17.1
Educational level (college/university or higher, %) 12.4 12.8 12.5 11.7 10.3
Alcohol drinking (drinkers, %) 19.5 19.0 18.6 19.1 18.8
Smoking (smokers, %) 10.3 7.6 5.9 5.7 5.8
Walking status (o1h per day, %) 44.7 46.6 45.1 46.1 49.2
Family history of breast cancer in mother or sisters (%) 1.8 1.7 2.3 2.0 2.0
Age at menarche (mean, years) 15.4±2.1 15.3±1.9 15.3±2.0 15.2±2.0 15.2±2.1
Age at menarche (16 years p, %) 37.2 35.9 36.2 34.7 32.4
Age at natural menopause (mean, years) 49.1±3.8 49.5±3.6 49.4±3.4 49.4±3.7 49.7±3.7
Parity (nulliparous, %) 3.7 2.7 1.8 2.3 2.2
Parity number among parous women (mean) 2.6±1.0 2.6±1.0 2.7±1.0 2.7±1.0 2.8±1.1
Exogenous female hormone use (users, %) 11.7 10.6 9.9 10.8 10.0
Height (mean, cm) 152.4±6.7 151.7±5.2 151.5±5.0 151.5±4.9 150.7±5.3
o20.5 p20.5 o22.0 p22.0 o23.8 p23.8
BMI at age 20 years
Number of subjects 2577 2460 2594 2475
Age (mean, years) 56.9±4.4 57.1±4.3 57.3±4.3 57.6±4.2
Occupation (no occupation/housewife, %) 19.0 17.1 16.3 14.0
Educational level (college/university or higher, %) 14.0 12.7 10.8 9.5
Alcohol drinking (drinkers, %) 20.0 17.5 18.6 19.6
Smoking (smokers, %) 7.3 6.0 6.1 6.8
Walking status (o1h per day, %) 48.7 45.6 47.0 44.7
Family history of breast cancer in mother or sisters (%) 2.3 1.5 2.1 2.0
Age at menarche (mean, years) 15.4±2.0 15.2±1.9 15.3±2.0 15.3±2.1
Age at menarche (16 years p, %) 36.7 33.3 35.0 34.7
Age at natural menopause (mean, years) 49.3±3.7 49.4±3.5 49.5±3.7 49.6±3.6
Parity (nulliparous, %) 3.7 2.0 2.0 1.8
Parity number among parous women (mean) 2.6±1.0 2.7±1.0 2.7±1.1 2.8±1.1
Exogenous female hormone use (users, %) 11.6 9.9 10.2 10.1
Height (mean, cm) 152.9±5.8 151.6±4.7 151.0±5.0 150.2±5.4
Table 2 Characteristics of study population according to weight change from age 20 to the current age
Characteristics Weight loss
a Stable weight
b Weight gain
c
Number of subjects 2801 758 6547
Age (mean, years) 57.4±4.3 57.1±4.4 57.2±4.3
Occupation (no occupation/housewife, %) 14.6 16.1 17.5
Education level (college/university or higher, %) 10.6 13.6 12.0
Alcohol drinking (drinkers, %) 19.4 18.2 18.9
Smoking (smokers, %) 8.0 6.3 6.0
Walking status (o1h per day, %) 43.5 44.7 48.1
Family history of breast cancer in mother or sisters (%) 1.6 3.2 2.0
Age at menarche (mean, years) 15.4±2.0 15.1±1.9 15.2±2.0
Age at menarche (16 years p, %) 37.9 30.0 34.3
Age at natural menopause (mean, years) 49.5±3.6 49.3±3.4 49.5±3.6
Parity (nulliparous, %) 2.2 3.0 2.4
Parity number among parous women (mean) 2.7±1.0 2.7±1.0 2.7±1.0
Exogenous female hormone use (users, %) 10.2 12.4 10.3
Height (mean, cm) 150.8±5.5 151.3±5.2 151.7±5.3
Weight at 20 years (mean, kg) 54.7±6.2 51.3±6.1 49.0±5.4
Current body mass index (mean) 21.6±2.3 22.4±2.4 25.2±2.9
Weight change was evaluated for subjects with complete data for height.
aWeight loss X2kg.
bWeight gain or loss o2kg.
cWeight gain X2kg.
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a clearer inverse association with weight loss was observed. These
results might have been expected from the different associations of
risk with BMI at the current age and at age 20 years, as mentioned
above. To our knowledge, this is the first prospective cohort study
to have evaluated the association between weight change and BC
risk among Japanese women. The positive effect of weight gain has
been observed in nearly all prospective studies from Western
countries (Ahn et al, 2007; Barnes-Josiah et al, 1995; Eliassen et al,
2006; Feigelson et al, 2004; Lahmann et al, 2005). On the other
hand, the relationship of weight loss to risk has not been fully
investigated (Eliassen et al, 2006; Harvie et al, 2005; Hirose et al,
1999; Kyogoku et al, 1990; Lahmann et al, 2005). Although most of
the studies have observed a null or non-significant association, a
few have demonstrated a significantly decreased postmenopausal
risk associated with adult weight loss (Eliassen et al, 2006). Our
results provide additional evidence for the association with adult
weight change, especially weight loss.
Strengths of our study included its prospective design and the
high quality of the follow-up. Although this cohort was relatively
small scale, participants were recruited from the general popula-
tion, and BC cases were identified from the population-based
cancer registry. Furthermore, the rate of loss to follow-up was low,
so selection and information bias were avoided. Limitations
included, first, the fact that weights at age 20 years and at current
age, and height, were self-reported. The correlations between
measured and self-reported current weight and height were high.
On the other hand, there were no data for measured weight at age
20years. The self-recalled weight at age 20 years may have been
lower or higher than the real weight, thus causing a non-
differential misclassification bias. However, it is unlikely that this
bias would have seriously distorted the results (Rothman and
Greenland, 1998). Second, our results may have been contaminated
subclinical effects of BC by cases occurring soon after recruitment.
We, therefore, analyzed the data after omitting cases that occurred
within 2 years of recruitment, but this yielded almost the same
results (data not shown).
This study has found that adiposity at younger and current age
has differential effects on BC risk, and that weight change during
adulthood is associated with the postmenopausal risk among
Japanese women; weight gain was associated with an increased
risk, and weight loss with a decreased risk. As body weight is a
modifiable lifestyle factor, weight control throughout life appears
to be useful in BC.
Table 3 Hazard ratio (HR) and 95% confidence interval (CI) of breast cancer according to current body mass index (BMI) and BMI at age 20 years
Age-adjusted model Multivariate-adjusted model 1
a Multivariate-adjusted model 2
Person-years Cases HR 95% CI HR 95% CI HR 95% CI
Current BMI
o20.5 15327 8 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
b
20.5po 22.0 19121 15 1.50 0.64–3.54 1.51 0.64–3.56 1.63 0.69–3.86
22.0po 23.8 29835 24 1.54 0.69–3.43 1.55 0.70–3.46 1.74 0.78–3.90
23.8po 25.9 32575 27 1.59 0.72–3.49 1.64 0.74–3.61 1.86 0.84–4.12
25.9p 33033 34 1.97 0.91–4.25 2.04 0.94–4.41 2.54 1.16–5.55
P for trend 0.09 0.07 0.02
BMI at age 20 years
o20.5 32880 37 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
c
20.5po 22.0 31555 29 0.82 0.50–1.33 0.88 0.54–1.44 0.83 0.51–1.36
22.0po 23.8 33460 28 0.74 0.45–1.21 0.80 0.49–1.31 0.72 0.44–1.19
23.8p 31996 14 0.39 0.21–0.72 0.44 0.24–0.81 0.38 0.20–0.70
P for trend 0.003 0.01 0.002
aAdjusted for age (continuous variable), alcohol drinking (ever, never), smoking (ever, never), occupation (permanent, no occupation/housewife), walking (o1h per day, longer
than 1h per day), education level (junior high school or less, high school, college/university or higher), age at menarche (p13, 14, 15, 16o), age at menopause (p47, 48pp 50,
51pp 53, 54p), parity number (0, 1, 2, 3, 4, 5p), family history of breast cancer (present, absent) and history of exogenous female hormone use (ever, never).
bAdditionally
adjusted for BMI at age 20 years (o20.5, 20.5po 22.0, 22.0po 23.8, 23.8p).
cAdditionally adjusted for current BMI (o20.5, 20.5po 22.0, 22.0po 23.8, 23.8po 25.9,
25.9p).
Table 4 Hazard ratio (HR) and 95% confidence interval (CI) of breast cancer according to weight change from age 20 years to the current age
Age-adjusted model Multivariate-adjusted model
a
Weight change (kg) Person-years Cases HR 95% CI HR 95% CI
p 5 19760 5 0.31 0.10–0.94 0.35 0.11–1.10
 5op  2 16128 13 0.98 0.41–2.36 1.05 0.43–2.55
 2oo +2 9714 8 1.00 (Reference) 1.00 (Reference)
+2po +5 18765 11 0.71 0.29–1.77 0.70 0.28–1.75
+5po +8 22857 21 1.12 0.49–2.52 1.09 0.48–2.47
+8po +12 20100 19 1.15 0.50–2.62 1.10 0.48–2.53
+12p 22567 31 1.67 0.77–3.63 1.55 0.70–3.45
P for trend 0.0002 0.0086
P for weight loss trend 0.03 0.04
P for weight gain trend 0.02 0.05
aAdjusted for age (continuous variable), height (o149, 149po 152, 152po 156, 156p), body weight at age 20 (continuous variable), alcohol drinking (ever, never), smoking
(ever, never), occupation (permanent, no occupation/housewife), walking (o1h per day, longer than 1h per day), education level (junior high school or less, high school, college/
university or higher), age at menarche (p13, 14, 15, 16o), age at menopause (p47, 48pp 50, 51pp 53, 54p), parity number (0, 1, 2, 3, 4, 5p), family history of breast
cancer (present, absent) and history of exogenous female hormone use (ever, never).
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